HomeLYRA • NASDAQ
add
Lyra Therapeutics Inc
Previous close
$0.19
Day range
$0.19 - $0.20
Year range
$0.16 - $6.79
Market cap
12.91M USD
Avg Volume
2.39M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 195.00K | -64.15% |
Operating expense | 3.93M | -21.43% |
Net income | -11.87M | 24.14% |
Net profit margin | -6.09K | -111.63% |
Earnings per share | -0.14 | 48.70% |
EBITDA | -9.60M | 42.74% |
Effective tax rate | -0.06% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 51.63M | -49.66% |
Total assets | 78.76M | -34.68% |
Total liabilities | 58.14M | 60.00% |
Total equity | 20.62M | — |
Shares outstanding | 65.46M | — |
Price to book | 0.59 | — |
Return on assets | -27.80% | — |
Return on capital | -38.97% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -11.87M | 24.14% |
Cash from operations | -16.22M | -14.94% |
Cash from investing | 8.14M | 154.35% |
Cash from financing | -23.00K | 94.50% |
Net change in cash | -8.10M | 72.54% |
Free cash flow | -9.48M | -128.70% |
About
Founded
2005
Headquarters
Website
Employees
87
